Nathan Weinstein
Stock Analyst at Aegis Capital
(0.26)
# 4,387
Out of 5,182 analysts
59
Total ratings
13.33%
Success rate
-26.26%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $0.78 | +10,155.10% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $7.43 | +3,937.69% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.14 | +4,305.29% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $400 → $350 | $9.98 | +3,407.01% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $1.93 | +210.88% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $4.11 | +629.93% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $14.27 | -29.92% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $16.57 | +195.72% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $63,000 → $1,800 | $5.10 | +35,194.12% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $5.26 | +40,964.64% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.54 | +7,692.21% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.51 | +1,864.64% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $41.97 | +33.43% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $4.34 | +522.12% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $1.00 | +3,400.00% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.15 | +943.48% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $23.99 | +212.63% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.18 | +3,936.70% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.57 | +31,407.09% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $11.37 | +1,087.34% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $8.26 | +69.49% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $13.93 | +1,479.33% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $2.97 | +186.20% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $0.78
Upside: +10,155.10%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $7.43
Upside: +3,937.69%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.14
Upside: +4,305.29%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $400 → $350
Current: $9.98
Upside: +3,407.01%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $1.93
Upside: +210.88%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $4.11
Upside: +629.93%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $14.27
Upside: -29.92%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $16.57
Upside: +195.72%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $63,000 → $1,800
Current: $5.10
Upside: +35,194.12%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $5.26
Upside: +40,964.64%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $1.54
Upside: +7,692.21%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.51
Upside: +1,864.64%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $41.97
Upside: +33.43%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $4.34
Upside: +522.12%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $1.00
Upside: +3,400.00%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.15
Upside: +943.48%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $23.99
Upside: +212.63%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.18
Upside: +3,936.70%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $0.57
Upside: +31,407.09%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $11.37
Upside: +1,087.34%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $8.26
Upside: +69.49%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $13.93
Upside: +1,479.33%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $2.97
Upside: +186.20%